Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials

BACKGROUND: We performed a systematic review and meta-analysis to determine the efficacy and safety of the US Food and Drug Administration approved vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in the treatment of advanced thyroid cancer. PATIENTS AND METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Yimaer, Wufuer, Abudouyimu, Aizizi, Tian, Ye, Magaoweiya, Sailike, Bagedati, Duman, Wen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789842/
https://www.ncbi.nlm.nih.gov/pubmed/27022276
http://dx.doi.org/10.2147/OTT.S102265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789842/
https://www.ncbi.nlm.nih.gov/pubmed/27022276
http://dx.doi.org/10.2147/OTT.S102265

Ejemplares similares